Drug Type Small molecule drug |
Synonyms- |
Target |
Action activators |
Mechanism PINK1 activators(PTEN induced kinase 1 activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | United States | 10 Jul 2025 |